Cost-effectiveness analysis of increasing drug therapy coverage for patients with coronary artery disease in combination with atrial fibrillation and heart failure

Cost-effectiveness analysis of increasing drug therapy coverage for patients with coronary artery disease in combination with atrial fibrillation and heart failure

Aim. To make a cost-effectiveness analysis of increasing the prescription rate of combination therapy with beta-blockers (BBs), angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs), statins and oral anticoagulants (OACs) in patients with coronary artery disease (CAD...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: V. I. Ignatieva, A. V. Kontsevaya, M. M. Lukyanov, V. G. Klyashtorny, O. M. Drapkina
Natura: Articolo
Lingua:russo
Pubblicazione: «SILICEA-POLIGRAF» LLC 2024-05-01
Serie:Кардиоваскулярная терапия и профилактика
Soggetti:
combination of coronary artery disease
heart failure and atrial fibrillation
drug therapy coverage
clinical and economic study
Accesso online:https://cardiovascular.elpub.ru/jour/article/view/3950
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Lascia un commento!
Entra

Documenti analoghi